Clinical Trial
2018 Jun;200:17-23.
JOURNAL：Am J Cardiol.
Article Link
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial
Lopes RD, Vora AN, Liaw D et al.
KEYWORDS
apixaban; vitamin K antagonist; aspirin; placebo; ACS; PCI;
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
